Literature DB >> 4075613

Metastatic properties of murine sarcomas and carcinomas. I. Positive correlation with lung colonization and lack of correlation with s.c. tumor take.

J P Volpe, N Hunter, I Basic, L Milas.   

Abstract

The spontaneous metastatic properties of six sarcomas and seven carcinomas syngeneic to C3Hf/Kam mice were investigated and the correlation between spontaneous metastasis, the lung colony forming efficiency (LCFE) of i.v. injected tumor cells, and s.c. tumor take was determined. The incidence and number of spontaneous metastases in the lung were determined in mice that had primary tumors in the leg removed 17 to 120 days earlier, depending on tumor type. There was a significant positive correlation between spontaneous metastasis and LCFE when all 13 tumors were compared, but the significance was lost when carcinomas and sarcomas were considered separately. No significant correlation between spontaneous metastasis and the s.c. tumor take was observed. Also, no correlation was found between LCFE and the s.c. tumor take of carcinomas, but there was a strong inverse relationship between these two properties of sarcomas. The number of cells shed from primary tumors was estimated and found to be more extensive in tumors with higher metastatic properties. Thus, in general, highly metastatic tumors were characterized by a high LCFE and a significant cell shedding. Furthermore, LCFE was greatly increased by treatment of animals with cyclophosphamide and by admixing heavily irradiated tumor cells to viable cells, implying that local environmental factors are important in determining the establishment of tumor cell clonogens into metastasis.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4075613     DOI: 10.1007/BF01585082

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  25 in total

1.  Selection of successive tumour lines for metastasis.

Authors:  I J Fidler
Journal:  Nat New Biol       Date:  1973-04-04

2.  Immunological resistance to pulmonary metastases in C3Hf-Bu mice bearing syngeneic fibrosarcoma of different sizes.

Authors:  L Milas; N Hunter; K Mason; H R Withers
Journal:  Cancer Res       Date:  1974-01       Impact factor: 12.701

Review 3.  Tumor cell diversity and host responses in cancer metastasis--part I--properties of metastatic cells.

Authors:  G L Nicolson; G Poste
Journal:  Curr Probl Cancer       Date:  1982-12       Impact factor: 3.187

4.  Heterogeneity and variability of artificial lung colony-forming ability among clones from mouse fibrosarcoma.

Authors:  N Suzuki; H R Withers; M W Koehler
Journal:  Cancer Res       Date:  1978-10       Impact factor: 12.701

5.  The selection and characterization of an invasive variant of the B16 melanoma.

Authors:  I R Hart
Journal:  Am J Pathol       Date:  1979-12       Impact factor: 4.307

6.  Comparison of the metastatic properties of B16 melanoma clones isolated from cultured cell lines, subcutaneous tumors, and individual lung metastases.

Authors:  G Poste; J Doll; A E Brown; J Tzeng; I Zeidman
Journal:  Cancer Res       Date:  1982-07       Impact factor: 12.701

7.  Cancer metastasis is selective or random depending on the parent tumour population.

Authors:  J E Talmadge; I J Fidler
Journal:  Nature       Date:  1982-06-17       Impact factor: 49.962

8.  In vivo isolation of a metastatic tumor cell variant involving selective and nonadaptive processes.

Authors:  A Raz; N Hanna; I J Fidler
Journal:  J Natl Cancer Inst       Date:  1981-01       Impact factor: 13.506

9.  Heterogeneity in a spontaneous mouse lung carcinoma: selection and characterisation of stable metastatic variants.

Authors:  M G Layton; L M Franks
Journal:  Br J Cancer       Date:  1984-04       Impact factor: 7.640

10.  Do metastases arise from pre-existing subpopulations of cancer cells?

Authors:  L Weiss; J C Holmes; P M Ward
Journal:  Br J Cancer       Date:  1983-01       Impact factor: 7.640

View more
  12 in total

1.  Amifostine induces antioxidant enzymatic activities in normal tissues and a transplantable tumor that can affect radiation response.

Authors:  David J Grdina; Jeffrey S Murley; Yasushi Kataoka; Kenneth L Baker; Rangesh Kunnavakkam; Mitchell C Coleman; Douglas R Spitz
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-03-01       Impact factor: 7.038

Review 2.  Technical considerations for studying cancer metastasis in vivo.

Authors:  D R Welch
Journal:  Clin Exp Metastasis       Date:  1997-05       Impact factor: 5.150

3.  Metastatic abilities of murine sarcomas and carcinomas. II. Relationship to cell volume and DNA index.

Authors:  J P Volpe; I Basic; L Milas
Journal:  Clin Exp Metastasis       Date:  1990 Mar-Apr       Impact factor: 5.150

4.  The use of quantitative genetics for estimating the non-inherited and inherited contributions to metastasis formation.

Authors:  J P Volpe
Journal:  Clin Exp Metastasis       Date:  1992-05       Impact factor: 5.150

5.  Metastatic instability of murine tumor metastases: dependence on tumor type.

Authors:  J P Volpe; L Milas
Journal:  Clin Exp Metastasis       Date:  1988 Jul-Aug       Impact factor: 5.150

6.  Low E-cadherin and beta-catenin expression correlates with increased spontaneous and artificial lung metastases of murine carcinomas.

Authors:  T Akimoto; S Kawabe; A Grothey; L Milas
Journal:  Clin Exp Metastasis       Date:  1999-03       Impact factor: 5.150

7.  Combination of interleukin-2 and irradiation in therapy of murine tumors.

Authors:  N Hunter; T Nakayama; H Ito; S Woo; L Milas
Journal:  Clin Exp Metastasis       Date:  1992-11       Impact factor: 5.150

8.  Ischaemia-reperfusion injury in photodynamic therapy-treated mouse tumours.

Authors:  M Korbelik; J Sun; H Zeng
Journal:  Br J Cancer       Date:  2003-03-10       Impact factor: 7.640

9.  Photofrin accumulation in malignant and host cell populations of various tumours.

Authors:  M Korbelik; G Krosl
Journal:  Br J Cancer       Date:  1996-02       Impact factor: 7.640

10.  Potentiation of photodynamic therapy of cancer by complement: the effect of gamma-inulin.

Authors:  M Korbelik; P D Cooper
Journal:  Br J Cancer       Date:  2006-12-05       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.